MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jtcvs.2016.12.055

Медицинская библиотека · The Journal of thoracic and cardiovascular surgery · 2017

Pneumonia after cardiac surgery: Experience of the National Institutes of Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network.

Ailawadi Gorav, Chang Helena L, O'Gara Patrick T, O'Sullivan Karen, Woo Y Joseph, DeRose Joseph J, Parides Michael K, Thourani Vinod H, Robichaud Sophie, Gillinov A Marc, Taddei-Peters Wendy C, Miller Marissa A, Perrault Louis P, Smith Robert L, Goldsmith Lyn, Horvath Keith A, Doud Kristen, Baio Kim, Gelijns Annetine C, Moskowitz Alan J, Bagiella Emilia, Alexander John H, Iribarne Alexander

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

RATIONALE: Pneumonia remains the most common major infection after cardiac surgery despite numerous preventive measures.

OBJECTIVES

To prospectively examine the timing, pathogens, and risk factors, including modifiable management practices, for postoperative pneumonia and estimate its impact on clinical outcomes.

METHODS

A total of 5158 adult cardiac surgery patients were enrolled prospectively in a cohort study across 10 centers. All infections were adjudicated by an independent committee. Competing risk models were used to assess the association of patient characteristics and management practices with pneumonia within 65 days of surgery. Mortality was assessed by Cox proportional hazards model and length of stay by a multistate model.

MEASUREMENTS AND MAIN

RESULTS

The cumulative incidence of pneumonia was 2.4%, 33% of which occurred after discharge. Older age, lower hemoglobin level, chronic obstructive pulmonary disease, steroid use, operative time, and left ventricular assist device/heart transplant were risk factors. Ventilation time (24-48 vs ≤24 hours; hazard ratio [HR], 2.83; 95% confidence interval [95% CI], 1.72-4.66; >48 hours HR, 4.67; 95% CI, 2.70-8.08), nasogastric tubes (HR, 1.80; 95% CI, 1.10-2.94), and each unit of blood cells transfused (HR, 1.16; 95% CI, 1.08-1.26) increased the risk of pneumonia. Prophylactic use of second-generation cephalosporins (HR, 0.66; 95% CI, 0.45-0.97) and platelet transfusions (HR, 0.49, 95% CI, 0.30-0.79) were protective. Pneumonia was associated with a marked increase in mortality (HR, 8.89; 95% CI, 5.02-15.75) and longer length of stay of 13.55 ± 1.95 days (bootstrap 95% CI, 10.31-16.58).

CONCLUSIONS

Pneumonia continues to impose a major impact on the health of patients after cardiac surgery. After we adjusted for baseline risk, several specific management practices were associated with pneumonia, which offer targets for quality improvement and further research.

Для цитирования: Ailawadi Gorav, Chang Helena L, O'Gara Patrick T, O'Sullivan Karen, Woo Y Joseph, DeRose Joseph J, Parides Michael K, Thourani Vinod H, Robichaud Sophie, Gillinov A Marc, Taddei-Peters Wendy C, Miller Marissa A, Perrault Louis P, Smith Robert L, Goldsmith Lyn, Horvath Keith A, Doud Kristen, Baio Kim, Gelijns Annetine C, Moskowitz Alan J, Bagiella Emilia, Alexander John H, Iribarne Alexander. Pneumonia after cardiac surgery: Experience of the National Institutes of Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network.. The Journal of thoracic and cardiovascular surgery. 2017. DOI: 10.1016/j.jtcvs.2016.12.055.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.